Nuveen Asset Management’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | $1.96M | Sell |
131,859
-37,994
| -22% | -$566K | ﹤0.01% | 2398 |
|
2024
Q3 | $2.6M | Buy |
169,853
+2,552
| +2% | +$39K | ﹤0.01% | 2294 |
|
2024
Q2 | $2.55M | Buy |
167,301
+40,082
| +32% | +$610K | ﹤0.01% | 2266 |
|
2024
Q1 | $2.4M | Sell |
127,219
-6,228
| -5% | -$118K | ﹤0.01% | 2312 |
|
2023
Q4 | $2.55M | Sell |
133,447
-330,476
| -71% | -$6.31M | ﹤0.01% | 2301 |
|
2023
Q3 | $8.33M | Buy |
463,923
+5,780
| +1% | +$104K | ﹤0.01% | 1583 |
|
2023
Q2 | $9.3M | Buy |
458,143
+16,902
| +4% | +$343K | ﹤0.01% | 1557 |
|
2023
Q1 | $8.05M | Buy |
441,241
+298,925
| +210% | +$5.45M | ﹤0.01% | 1622 |
|
2022
Q4 | $2.94M | Sell |
142,316
-24,359
| -15% | -$504K | ﹤0.01% | 2205 |
|
2022
Q3 | $4.36M | Sell |
166,675
-4,956
| -3% | -$130K | ﹤0.01% | 1981 |
|
2022
Q2 | $4.35M | Sell |
171,631
-86,371
| -33% | -$2.19M | ﹤0.01% | 2036 |
|
2022
Q1 | $8.93M | Sell |
258,002
-1,224
| -0.5% | -$42.4K | ﹤0.01% | 1720 |
|
2021
Q4 | $10.1M | Sell |
259,226
-18,817
| -7% | -$731K | ﹤0.01% | 1688 |
|
2021
Q3 | $10.1M | Sell |
278,043
-147,031
| -35% | -$5.35M | ﹤0.01% | 1773 |
|
2021
Q2 | $11.7M | Buy |
425,074
+253,089
| +147% | +$6.95M | ﹤0.01% | 1771 |
|
2021
Q1 | $4.83M | Sell |
171,985
-32,804
| -16% | -$921K | ﹤0.01% | 2187 |
|
2020
Q4 | $5.32M | Sell |
204,789
-11,563
| -5% | -$300K | ﹤0.01% | 2042 |
|
2020
Q3 | $3.71M | Sell |
216,352
-65,075
| -23% | -$1.12M | ﹤0.01% | 2077 |
|
2020
Q2 | $6.96M | Buy |
281,427
+45,307
| +19% | +$1.12M | ﹤0.01% | 1715 |
|
2020
Q1 | $3.28M | Buy |
236,120
+49,958
| +27% | +$694K | ﹤0.01% | 1937 |
|
2019
Q4 | $1.88M | Buy |
186,162
+45,707
| +33% | +$462K | ﹤0.01% | 2441 |
|
2019
Q3 | $1.28M | Buy |
140,455
+6,962
| +5% | +$63.3K | ﹤0.01% | 2593 |
|
2019
Q2 | $1.06M | Buy |
+133,493
| New | +$1.06M | ﹤0.01% | 2705 |
|